Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208647124> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W3208647124 endingPage "540" @default.
- W3208647124 startingPage "531" @default.
- W3208647124 abstract "Consensus guidelines recommend high-dose corticosteroids (1-2 mg/kg/day methylprednisolone equivalents) for treating grade ≥3 immune checkpoint inhibitor (ICI) hepatitis. We examined the effect of corticosteroid dosing on time to alanine aminotransferase (ALT) normalization, need for additional immunosuppression, and steroid-related complications.We conducted a retrospective cohort study of 215 ICI-treated patients from 2010 to 2020 who developed grade ≥3 (ALT > 200 U/L) ICI hepatitis. Patients were grouped by initial corticosteroid dose (≥1.5 mg/kg or <1.5 mg/kg methylprednisolone equivalents). Propensity scores were calculated predicting the risk of receiving the higher steroid dose and used in inverse probability of treatment weighted (IPTW) logistic or Cox regression. The 87 patients in the ≥1.5 mg/kg group received higher initial (2.0 vs. 0.8 mg/kg/day, p < 0.001) and maximum (2.0 vs. 1.0 mg/kg/day, p < 0.001) steroid doses than the 128 patients in the <1.5 mg/kg group. There was no difference between the higher versus lower-dose groups in development of steroid-refractory hepatitis (OR 1.22, 95% CI 0.79-1.89, p = 0.365) on IPTW-logistic regression. In patients with steroid-responsive disease, there was no difference between the two groups in time to ALT normalization using either standard Cox regression (HR 1.02, 95% CI 0.72-1.45, p = 0.903) or IPTW-Cox regression (HR 1.09, 95% CI 0.78-1.51, p = 0.610). The ≥1.5 mg/kg group had longer exposure to corticosteroids (median 60 vs. 44 days, p = 0.005) and higher incidences of infection (18.4% vs. 7.0%, relative risk [RR] 2.6, 95% CI 1.2-5.6, p = 0.011) and hyperglycemia requiring treatment (23.3% vs. 7.8%, RR 3.0, 95% CI 1.5-6.0, p = 0.001).In patients with high-grade ICI hepatitis, initial treatment with 1 mg/kg/day methylprednisolone equivalents provides similar hepatitis outcomes with reduced risk of steroid-related complications when compared with higher-dose regimens." @default.
- W3208647124 created "2021-11-08" @default.
- W3208647124 creator A5017969215 @default.
- W3208647124 creator A5021274309 @default.
- W3208647124 creator A5036658494 @default.
- W3208647124 creator A5059003829 @default.
- W3208647124 creator A5061496922 @default.
- W3208647124 creator A5078674826 @default.
- W3208647124 creator A5080783554 @default.
- W3208647124 creator A5084967339 @default.
- W3208647124 date "2021-12-07" @default.
- W3208647124 modified "2023-10-16" @default.
- W3208647124 title "Effect of corticosteroid dosing on outcomes in high‐grade immune checkpoint inhibitor hepatitis" @default.
- W3208647124 cites W1976167126 @default.
- W3208647124 cites W2037462205 @default.
- W3208647124 cites W2126049444 @default.
- W3208647124 cites W2141351444 @default.
- W3208647124 cites W2177405394 @default.
- W3208647124 cites W2259730793 @default.
- W3208647124 cites W2265285917 @default.
- W3208647124 cites W2347141054 @default.
- W3208647124 cites W2473218705 @default.
- W3208647124 cites W2549481046 @default.
- W3208647124 cites W2746991247 @default.
- W3208647124 cites W2783137027 @default.
- W3208647124 cites W2786816161 @default.
- W3208647124 cites W2792937256 @default.
- W3208647124 cites W2888599070 @default.
- W3208647124 cites W2895318254 @default.
- W3208647124 cites W2896600825 @default.
- W3208647124 cites W2945590213 @default.
- W3208647124 cites W2947829857 @default.
- W3208647124 cites W2952666958 @default.
- W3208647124 cites W3043703771 @default.
- W3208647124 cites W3092802874 @default.
- W3208647124 cites W3141296816 @default.
- W3208647124 doi "https://doi.org/10.1002/hep.32215" @default.
- W3208647124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34709662" @default.
- W3208647124 hasPublicationYear "2021" @default.
- W3208647124 type Work @default.
- W3208647124 sameAs 3208647124 @default.
- W3208647124 citedByCount "21" @default.
- W3208647124 countsByYear W32086471242022 @default.
- W3208647124 countsByYear W32086471242023 @default.
- W3208647124 crossrefType "journal-article" @default.
- W3208647124 hasAuthorship W3208647124A5017969215 @default.
- W3208647124 hasAuthorship W3208647124A5021274309 @default.
- W3208647124 hasAuthorship W3208647124A5036658494 @default.
- W3208647124 hasAuthorship W3208647124A5059003829 @default.
- W3208647124 hasAuthorship W3208647124A5061496922 @default.
- W3208647124 hasAuthorship W3208647124A5078674826 @default.
- W3208647124 hasAuthorship W3208647124A5080783554 @default.
- W3208647124 hasAuthorship W3208647124A5084967339 @default.
- W3208647124 hasConcept C126322002 @default.
- W3208647124 hasConcept C151956035 @default.
- W3208647124 hasConcept C167135981 @default.
- W3208647124 hasConcept C17923572 @default.
- W3208647124 hasConcept C2776804153 @default.
- W3208647124 hasConcept C2777288759 @default.
- W3208647124 hasConcept C2780372218 @default.
- W3208647124 hasConcept C50382708 @default.
- W3208647124 hasConcept C71924100 @default.
- W3208647124 hasConcept C72563966 @default.
- W3208647124 hasConcept C90924648 @default.
- W3208647124 hasConceptScore W3208647124C126322002 @default.
- W3208647124 hasConceptScore W3208647124C151956035 @default.
- W3208647124 hasConceptScore W3208647124C167135981 @default.
- W3208647124 hasConceptScore W3208647124C17923572 @default.
- W3208647124 hasConceptScore W3208647124C2776804153 @default.
- W3208647124 hasConceptScore W3208647124C2777288759 @default.
- W3208647124 hasConceptScore W3208647124C2780372218 @default.
- W3208647124 hasConceptScore W3208647124C50382708 @default.
- W3208647124 hasConceptScore W3208647124C71924100 @default.
- W3208647124 hasConceptScore W3208647124C72563966 @default.
- W3208647124 hasConceptScore W3208647124C90924648 @default.
- W3208647124 hasIssue "3" @default.
- W3208647124 hasLocation W32086471241 @default.
- W3208647124 hasLocation W32086471242 @default.
- W3208647124 hasOpenAccess W3208647124 @default.
- W3208647124 hasPrimaryLocation W32086471241 @default.
- W3208647124 hasRelatedWork W2000278658 @default.
- W3208647124 hasRelatedWork W2422505000 @default.
- W3208647124 hasRelatedWork W2980864243 @default.
- W3208647124 hasRelatedWork W3007385212 @default.
- W3208647124 hasRelatedWork W3108139128 @default.
- W3208647124 hasRelatedWork W3113146271 @default.
- W3208647124 hasRelatedWork W3115343760 @default.
- W3208647124 hasRelatedWork W4235834539 @default.
- W3208647124 hasRelatedWork W4245734345 @default.
- W3208647124 hasRelatedWork W4256123815 @default.
- W3208647124 hasVolume "75" @default.
- W3208647124 isParatext "false" @default.
- W3208647124 isRetracted "false" @default.
- W3208647124 magId "3208647124" @default.
- W3208647124 workType "article" @default.